Search
Sumario de resultados
TIpos de contenido
Fecha
-
-
NewBCN HEALTH publishes a study evaluating the incidence and costs associated with osteogenes...
BCN HEALTH conducted a retrospective study using records of patients diagnosed with osteogenesis imperfecta who were treated in public and private hospitals in Spain between 2000 and 2017.
-
NewNatac obtains the ‘Calculate and Reduce’ seal
The company has achieved a 14.44% reduction in the average emission intensity for the 2022–2024 period compared to 2021–2023, for scopes 1+2
-
CompanyREVEAL GENOMICS
-
NewBiohope Announces Collaboration to Advance Immunobiogram Diagnostic Solution to Optimize I...
Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has signed a know-how agreement with Mayo Clinic, a global leader in medical research
-
NewA pivotal year for PVpharm, which, in addition to its pharmacovigilance and clinical safet...
Among the most notable milestones are the sponsorship of the first edition of the Pharmacovigilance Forum, which featured the participation of the AEMPS (Spanish Agency of Medicines and Medical
-
NewORYZON presents data for iadademstat combinations in AML at the American Society of Hemato...
100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients
-
NewViva In Vitro Diagnostics and Vall d’Hebron launch a new research project to enable early ...
The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital, led by Dr. Ricard Ferrer, an international leader in sepsis.
-
-
NewIntegra Therapeuticsappoints Miles Gerson as Independent Chairman
Integra Therapeutics strengthens its corporate governance with the appointment of Miles Gerson as Independent Chair of its Board of Directors. With more than two decades of experience in investment
-
NewNuage Therapeutics obtains €2.7 million to develop a pioneering treatment against the most...
A public-private consortium led by the biotechnology company Nuage Therapeutics, together with the Spanish National Cancer Research Center (CNIO), the European Molecular Biology Laboratory (EMBL) and
-
NewThe European sector urges the EU to avoid new restrictions and to conclude a coherent, sci...
The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New Genomic Techniques (NGTs) and the food and feed derived from them.
-
Press releaseThe European sector urges the EU to avoid new restrictions and to conclude a coherent, sci...
The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New Genomic Techniques (NGTs) and the food and feed derived from them. After months
-
New#NewAseBioMember | " AseBio represents a space that raises the collective bar: being a mem...
Meet BePharma Institute, our new memeber. We spoke with Pedro Gonzáles Sánchez, manager.
-
New#NewAseBioMember | "AseBio is the meeting point of the Spanish biotechnology ecosystem"
Meet Neural Omega, our new member. We spoke with Pedro Bernardo Martín-Borregon, Founder & CEO.
-
NewJoan Puig: "In inorganic growth in Europe, cultural difference is one of the most importan...
Joan Puig, a graduate in Pharmacy and in Business Administration and Management, and with a General Management Programme (PDG) from IESE, has an extensive background in the field of analytical and
-
NewAdigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d...
The aim of this document is to promote a specific regulatory framework that recognises these technologies as a strategic sector for the country’s technological autonomy and competitiveness, as well as
-
Press releaseAdigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d...
The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities containing 13 concrete proposals to respond to the public consultation and guide
-
-
NewBiotechnology, key to curbing antimicrobial resistance and strengthening European health s...
In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, with 35,000 annual deaths in Europe and nearly 4,000 in Spain.
-
Press releaseBiotechnology, key to curbing antimicrobial resistance and strengthening European health s...
In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, including 35,000 annual deaths in Europe and around 4,000 in Spain. The WHO warns of a sustained increase in